富血小板血浆联合玻璃酸钠关节内注射对膝骨关节炎膝关节功能及疼痛的影响被引量：6

下载PDF

导出

摘要目的分析富血小板血浆联合玻璃酸钠关节内注射对膝骨关节炎患者膝关节功能及疼痛的影响。方法采用前瞻性研究,在2016年9月至2017年9月期间根据本研究相关标准纳入膝骨关节炎患者105例,用随机数字表法分为3组,各组35例;A组采用膝关节注射5 ml自体富血小板血浆(platelet-rich plasma,PRP),B组采用膝关节内注射2 ml玻璃酸钠(hyaluronic acid sodium,HA)治疗,C组采用5 ml膝关节内PRP注射10 min后注射2 ml HA。每周治疗1次,共治疗5周。使用Lysholm膝节评分系统评估患者膝关节功能恢复情况,使用WOMAC评估膝骨关节炎炎症严重程度。观察时间为治疗前、治疗后1、3及6个月。结果3组治疗后Lysholm分值逐渐升高,C组较B组和C组高;治疗后3组WOMAC分值均逐渐降低,C组较A组和B组低;差异均有统计学意义(P<0.05)。结论富血小板血浆联合玻璃酸钠关节内注射能促进膝关节功能恢复,值得推广。

作者姜波

机构地区新乡市中心医院骨二科(关节外科)

出处《内蒙古医学杂志》 2020年第7期841-842,共2页 Inner Mongolia Medical Journal

基金河南省2015年科技发展计划(编号:152300410012)

关键词富血小板血浆玻璃酸钠膝骨关节炎膝关节功能

分类号 R684.3 [医药卫生—骨科学]

引文网络
相关文献

参考文献4

1张成宝,马信龙,马剑雄,王颖,王辰,姜轩,孙磊.富血小板血浆与透明质酸治疗膝骨关节炎疗效的Meta分析[J].实用医学杂志,2015,31(22):3772-3774. 被引量：13
2吕帅洁,厉驹,何斌,易立明,金红婷,沈兴潮,童培建.富血小板血浆关节内注射治疗膝骨关节炎的前瞻性随机对照研究[J].中华创伤杂志,2016,32(7):626-631. 被引量：31
3谢磊,刘佳,王华军,聂喜增,刘金辉,关健,梁斌,丁罗宾.关节腔注射透明质酸及富血小板血浆对老年膝骨关节炎的治疗作用比较[J].中国老年学杂志,2018,38(5):1129-1131. 被引量：14
4谢磊,刘佳,王华军,聂喜增,刘金辉,关健,梁斌,丁罗宾.关节腔注射富血小板血浆对膝关节骨性关节炎的治疗效果[J].中国老年学杂志,2017,37(4):959-960. 被引量：40

二级参考文献34

1袁霆,张长青.骨组织及软组织修复作用中富血小板血浆的制作及其原理[J].中国临床康复,2004,8(35):7939-7941. 被引量：83
2Raeissadat SA, Rayegani SM, Osteoarthritis Injection Choices Hassanabadi H, et al. Knee Platelet- Rich Plasma (PRP)Versus Hyaluronic Acid (A one-year randomized clinical trial) [.l]. Clin Med Insights Arthritis Musculoskelet Disord, 2015,8: 1-8.
3Vaquerizo V, Plasencia MA, Arribas I, et al. Comparison of intra-articular injections of plasma rich in growth factors ( PRGF- Endoret) versus Durolane hyaluronic acid in the treatment ofpatients with symptomatic osteoarthritis: a randomized controlled trial [J]. Arthroscopy, 2013,29(10) : 1635-1643.
4Cerza F, Carni S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis [J]. Am J Sports Med, 2012,40(12) : 2822-2827.
5Filardo G, Kon E, Di MA, et al. Platelet-rich plasma vs hyaluronie acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial [ J ]. BMC Musculoskelet Disord, 2012,13 : 229.
6Sanchez M, Fiz N, Azofra J, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis [J]. Arthroscopy, 2012,28(8):1070-1078.
7Spakova T, Rosocha J, Lacko M, et al. Treatment of knee jointosteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid [J]. Am J Phys Med Rehabil, 2012,91 (5) :411-417.
8Kon E, Mandelbaum B, Buda R, et al. Platelct-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis [J]. Arthroscopy, 2011,27 ( 11 ) : 1490-1501.
9Gobbi A, Lad D, Karnatzikos G. The effects of repeated intra- articular PRP injections on clinical outcomes of early osteoarthritis of the knee[J]. Knee Snrg Sports Traumatol Arthrosc, 2014, 23 (8) :2170-2177. DOI:I0. 1007/s00167-014-2987-4.
10Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intra- articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis [ J]. Knee Surg Sports Tranmatol Arthrosc, 2011, 19 (4):528-535. DOI:10. 1007/s00167-010-123845.